Gross O, Audetat V, Bircher J
Schweiz Med Wochenschr. 1978 Sep 9;108(36):1389-93.
Although quantitative tests of some hepatic functions have been well established, the determination of serum cholinesterase activity continues to be commonly used in their stead. A critical comparison of the serum cholinesterase activity with these quantitative tests, however, is still lacking. Serum cholinesterase activity was therefore simultaneously compared with galactose elimination capacity (GEC), initial BSP-disappearance rate (BSP-ki), and serum albumin levels in 19 healthy control subjects and 46 patients with various chronic liver diseases. Serum cholinesterase activity was less discriminating between controls and patients than BSP-ki. It appears poorly suited, therefore, as a screening test for mild liver disease. Rank correlations between serum cholinesterase activity and GEC, BSP-ki, and serum albumin were statistically higher significant (r = 0.65, r = 0.74, and r = 0.80 respectively). On a statistical basis, serum cholinesterase activity may, therefore, be regarded as an index of the functional reserve of the liver. Evaluation of individual cases, however, revealed some clinically relevant discrepancies. It is concluded, therefore, that for accurate follow-up studies measurements of serum cholinesterase activity may be insufficient substitutes for the quantitative tests.
尽管一些肝功能的定量检测方法已经确立,但血清胆碱酯酶活性测定仍被普遍采用。然而,血清胆碱酯酶活性与这些定量检测方法的关键比较仍未进行。因此,我们对19名健康对照者和46名患有各种慢性肝病的患者同时进行了血清胆碱酯酶活性与半乳糖清除能力(GEC)、BSP初始消失率(BSP-ki)以及血清白蛋白水平的比较。血清胆碱酯酶活性在区分对照者和患者方面不如BSP-ki。因此,它似乎不太适合作为轻度肝病的筛查检测方法。血清胆碱酯酶活性与GEC、BSP-ki和血清白蛋白之间的等级相关性在统计学上具有高度显著性(分别为r = 0.65、r = 0.74和r = 0.80)。因此,从统计学角度来看,血清胆碱酯酶活性可被视为肝脏功能储备的一个指标。然而,对个别病例的评估显示出一些临床上相关的差异。因此得出结论,对于准确的随访研究,血清胆碱酯酶活性的测量可能不足以替代定量检测。